Testing effectiveness (Phase 2)Ended earlyNCT04353661
What this trial is testing
¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications
Who this might be right for
Chronic Obstructive Pulmonary Disease
Genentech, Inc. 12